ArticleACS omega2025
Leveraging a Meta-Learning Strategy to Advance the Accuracy of Neutralizing Antibodies against Dengue Virus Serotype Prediction.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue remains a major global public health threat with millions of infections reported annually and no widely effective treatment options available. Therapeutic monoclonal antibodies, particularly broadly neutralizing antibodies (bNAbs), show promise as treatments due to their ability to target conserved viral epitopes across all DENV serotypes. However, characterizing dengue virus (DENV) through experimental approaches remains expensive and time-consuming. Therefore, computational methods capable of identifying bNAbs against DENV from antibodies (CDR-H3) and epitope information can greatly complement experimental approaches and facilitate the rapid screening of bNAbs. Here, we propose an innovative meta-learning approach, termed Meta-iNAb, that can accurately identify bNAbs against DENV based on CDR-H3 and epitope information. In Meta-iNAb, to extract the diverse information on bNAbs, we employed 14 different feature encoding methods, incorporating sequential information, physicochemical properties, and composition-transition-distribution information. Then, each feature descriptor was used to construct base-classifiers using 12 popular machine learning (ML) algorithms. Finally, the 9 informative base-classifiers were selected using our customized genetic algorithm and subsequently combined to construct our meta-classifier. Benchmarking experiments revealed that Meta-iNAb is highly effective, outperforming the existing method and its base-classifiers during independent testing, with an accuracy of 0.851, an MCC of 0.702, an F1 score of 0.836, and an AUC of 0.883. To enable the rapid and efficient identification of bNAbs against DENV, an online web server for Meta-iNAb (https://pmlabqsar.pythonanywhere.com/Meta-iNAb) has been implemented. This innovative method is anticipated to serve as a high-accuracy and efficient tool for the rapid screening of stable and potent NAbs targeting DENV-1 to DENV-4.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.